Financials Neusoft Xikang Holdings Inc.
Equities
9686
KYG6461A1094
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 USD | +2.20% | +2.20% | -32.12% |
02/05 | Neusoft Xikang's Loss Narrows in 2023 Despite Revenue Drop | MT |
03/04 | Neusoft Xikang Holdings Inc. Change of Address of Head Office and Principal Place of Business in the PRC | CI |
Valuation
Fiscal Period: December | 2023 |
---|---|
Capitalization 1 | 1,048 |
Enterprise Value (EV) 1 | 795.6 |
P/E ratio | -5.46 x |
Yield | - |
Capitalization / Revenue | 1.95 x |
EV / Revenue | 1.48 x |
EV / EBITDA | -8.66 x |
EV / FCF | -1,01,61,809 x |
FCF Yield | -0% |
Price to Book | 2.45 x |
Nbr of stocks (in thousands) | 8,41,877 |
Reference price 2 | 1.245 |
Announcement Date | 29/04/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 503 | 614.3 | 687.4 | 537.7 |
EBITDA 1 | -95.21 | -244.2 | -161.5 | -91.88 |
EBIT 1 | -126.4 | -261.9 | -173.7 | -102.6 |
Operating Margin | -25.13% | -42.63% | -25.27% | -19.08% |
Earnings before Tax (EBT) 1 | -203 | -292.8 | -238.3 | -147.6 |
Net income 1 | -196.4 | -296.5 | -242 | -154.7 |
Net margin | -39.05% | -48.27% | -35.2% | -28.76% |
EPS 2 | -0.3170 | -0.4774 | -0.3895 | -0.2279 |
Free Cash Flow | - | 22.89 | -46.66 | -78.29 |
FCF margin | - | 3.73% | -6.79% | -14.56% |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 17/09/23 | 17/09/23 | 17/09/23 | 29/04/24 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 10.1 | 75.8 | 208 | - |
Net Cash position 1 | - | - | - | 253 |
Leverage (Debt/EBITDA) | -0.1059 x | -0.3103 x | -1.285 x | - |
Free Cash Flow | - | 22.9 | -46.7 | -78.3 |
ROE (net income / shareholders' equity) | - | 148% | 68.2% | 2,491% |
ROA (Net income/ Total Assets) | - | -17.2% | -11.5% | -5.5% |
Assets 1 | - | 1,723 | 2,097 | 2,812 |
Book Value Per Share 2 | -0.2100 | -0.4400 | -0.7300 | 0.5100 |
Cash Flow per Share 2 | 0.6300 | 0.5900 | 0.5600 | 0.8000 |
Capex 1 | 107 | 18.4 | 7.34 | 4.27 |
Capex / Sales | 21.24% | 2.99% | 1.07% | 0.79% |
Announcement Date | 17/09/23 | 17/09/23 | 17/09/23 | 29/04/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-32.12% | 10Cr | |
+6.88% | 3.33TCr | |
+20.58% | 796.05Cr | |
+31.48% | 425.2Cr | |
-29.55% | 266.85Cr | |
-27.55% | 128.28Cr | |
-30.53% | 120.1Cr | |
+11.69% | 100Cr | |
-35.42% | 90Cr | |
-20.77% | 69Cr |
- Stock Market
- Equities
- 9686 Stock
- Financials Neusoft Xikang Holdings Inc.